Apoptotic signaling induced by Tiazofurin-an in vitro study

Gene Therapy and Molecular Biology

Volumn 10, Issue 2, 2006, Pages 199-205

  Pathak, Sujata ^a   Sharma, Himani ^a   Chandresh Sharma, H ^a   Jayaram, Iremagalur N ^b   Singh, Neeta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cytochrome c; Mitochondria; Tiazofurin

Indexed keywords

EID: 47149102768     PISSN: 15299120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ashkenazi A and Dixit VM (1998) Death receptors: signalling and modulation. Science 281, 1305-1308.
2. Borner C (2003) The Bcl-2 protein family: sensors and checkpoints for life or death decisions. Mol Immunol 39, 615-647.
3. Budihardjo I, Oliver H, Lutter M, Luo H and Whang X (1999) Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15, 269-290.
4. Calviello G, di Nicuolo F, Piccioni E, Marcocci ME, Serini S, Maggiano N, Jones KH, Cornwell DG, Palloza P (2003) γ Tocopheryl quinone induces apoptosis in cancer cells via caspase-9 activation and cytochrome C release. Carcinogenesis 24, 427-433.
5. Colovic M, Sefer D, Bogdanovic A, Suvajdzic N, Jankovic G, Atkinson HD, Milenkovic P (2003) In vitro sensitivity of hematopoietic progenitors to tiazofurin in refractory acute myeloid leukemia and in the blast crisis of chronic myeloid leukemia. Cancer Lett 195, 153-159.
6. Gorman AM, Bonfoco E, Zhivotovsky B, Orrenius S, Ceccatelli S (1999) Cytochrome C release and caspase-3 activation during colchicines-induced apoptosis of cerebellar granule cells. Eur J Neurosci 11, 1067-1072.
7. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281, 1309-1312.
8. Grifantini M. (2000). Tiazoftirine ICN Pharmaceuticals. Curr Opin Investig Drugs 1, 257-262.
9. Grusch M, Rosenberger G, Fuhrmann G, Braun K, Titscher B, Szekeres T, Fritzer-Skekeres M, Oberhuber G, Krohn K, Hengstschaeger M, Kruptiza G, Jayaram HN (1999) Benzamide riboside induces apoptosis independent of Cdc25A expression in ovarian carcinoma N.I cells. Cell Death Differ 6, 736-744.
10. Hunakova L, Bies J, Sedlak J, Duraj J, Jakubikova J, Takacsova X, Novotny L (2000) Differential sensitivity of ovarian carcinoma cell lines to apptosis induced by the IMPDH inhibitor benzamide riboside. Neoplasma 47, 274-279.
11. Jayaram HN, Cooney DA, Grusen M, Krupitza G. (1999) Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis. Curr Med Chem 6, 561-574.
12. Ji C, Amarnath V, Peitenpol JA, Marnett LJ (2001) 4-hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome c release. Chem Res Toxicol 14, 1090-1096.
13. Khanna N, Jayaram HN, Singh N (2004) Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells. Life Sci 75, 179-190.
14. Lowe SW, Lin AW (2000) Apoptosis in cancer. Carcinogenesis 21, 485-495.
15. Novotny L, Rauko P, Yalowitz JA, Szekeres T (2002) Antitumor activity of Benzamide riboside in vitro and in vivo. Curr Med Chem 9, 773-779.
16. Sen S, Sharma H, Singh N (2005) Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Biochem Biophys Res Commun 33, 1245-1252.
17. Sharma H, Sen S, Singh N (2005) Molecular pathways in the chemosensitization of Cisplatin by quercetin in human head and neck cancer. Cancer Biol Ther 4, 949-55.
18. Singh N, Khanna N, Sharma H, Kundu S, Azmi S (2002) Insights into the molecular mechanism of apoptosis induced by TNF-α in mouse epidermal JB6-derived RT-101 cells. Biochem Biophys Res Commun 295, 24-30.
19. Strasser A, O'conor L, Dixit VM (2000) Apoptosis signalling. Annual Rev Biochem 69, 217-245.
20. Tatton WG, Olanow CW (1999) Apoptosis in neurodegenerative diseases: the role of mitochondria. Biochem Biophys Acta 1410, 195-213.
21. Tricot GJ, Jayaram HN, Lapis E, Natsumeda Y, Nichols CR, Kneebone P, Heerema N, Weber G, Hoffman R. (1989). Biochemically directed-therapy of leukemia with tiazofurin, a selective blocker of inosine 5′-phosphate dehydrogenase activity. Cancer Res. 49, 3696-3701.
22. Wright DG, Boosalis MS, Waraska K, Oshry LJ, Weintraub LR, Vosburgh E. (1996). Tiazofurin effects on IMP-dehydrogenase activity and expression in the leukemia cells of patients with CML blast crisis. Anticancer Res. 16:3349-51.
23. Wright DG, Boosalis M, Malek K, Waraska K (2004) Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies. Leuk Res 28, 1137-43.
24. Yalowitz JA, Pankiewicz K, Patterson SE, Jayaram HN (2002) Cytotoxicity and cellular differentiation activity of methylenebis (phosphonate) analogs of tiazofurin and mycophenolic acid adenine dinucleotide in human cancer cell lines. Cancer Lett 181, 31-8. Erratum in: Cancer Lett 199, 107-8.
25. Yuan XJ, Whang YE (2002) PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Oncogene 21, 319-327.